关注
Hussein A. Abbas, MD, PhD
Hussein A. Abbas, MD, PhD
在 mdanderson.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Mdm2 is required for survival of hematopoietic stem cells/progenitors via dampening of ROS-induced p53 activity
HA Abbas, DR Maccio, S Coskun, JG Jackson, AL Hazen, TM Sills, ...
Cell stem cell 7 (5), 606-617, 2010
1562010
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia
AGX Zeng, S Bansal, L Jin, A Mitchell, WC Chen, HA Abbas, ...
Nature medicine 28 (6), 1212-1223, 2022
1512022
Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates
V Chitsazzadeh, C Coarfa, JA Drummond, T Nguyen, A Joseph, ...
Nature communications 7 (1), 12601, 2016
1422016
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
Y Chu, E Dai, Y Li, G Han, G Pei, DR Ingram, K Thakkar, JJ Qin, M Dang, ...
Nature medicine 29 (6), 1550-1562, 2023
962023
The p53–Mdm2 feedback loop protects against DNA damage by inhibiting p53 activity but is dispensable for p53 stability, development, and longevity
V Pant, S Xiong, JG Jackson, SM Post, HA Abbas, A Quintás-Cardama, ...
Genes & development 27 (17), 1857-1867, 2013
912013
The prognostic and therapeutic role of genomic subtyping by sequencing tumor or cell-free DNA in pulmonary large-cell neuroendocrine carcinoma
M Zhuo, Y Guan, X Yang, L Hong, Y Wang, Z Li, R Chen, HA Abbas, ...
Clinical Cancer Research 26 (4), 892-901, 2020
862020
TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice
S Jiang, LC Minter, SA Stratton, P Yang, HA Abbas, ZC Akdemir, V Pant, ...
Journal of hepatology 62 (2), 371-379, 2015
752015
Endocrine and Bone Complications in β‐Thalassemia Intermedia: Current Understanding and Treatment
A Inati, MHA Noureldine, A Mansour, HA Abbas
BioMed research international 2015 (1), 813098, 2015
722015
Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy
HA Abbas, D Hao, K Tomczak, P Barrodia, JS Im, PK Reville, Z Alaniz, ...
Nature communications 12 (1), 6071, 2021
712021
Phase I/II study of azacitidine (AZA) with venetoclax (VEN) and magrolimab (Magro) in patients (pts) with newly diagnosed older/unfit or high-risk acute myeloid leukemia (AML …
N Daver, M Konopleva, A Maiti, TM Kadia, CD DiNardo, S Loghavi, ...
Blood 138, 371, 2021
692021
Association of Pre‐Pregnancy Body Mass Index and Gestational Weight Gain with Preterm Births and Fetal Size: an Observational Study from L ebanon
R El Rafei, HA Abbas, L Charafeddine, P Nakad, A Al Bizri, D Hamod, ...
Paediatric and perinatal epidemiology 30 (1), 38-45, 2016
582016
Azacitidine (AZA) with nivolumab (Nivo), and AZA with Nivo+ ipilimumab (Ipi) in relapsed/refractory acute myeloid leukemia: a non-randomized, prospective, phase 2 study
NG Daver, G Garcia-Manero, MY Konopleva, M Alfayez, N Pemmaraju, ...
Blood 134, 830, 2019
532019
Phase I/II study of azacitidine (AZA) with venetoclax (VEN) and magrolimab (Magro) in patients (pts) with newly diagnosed (ND) older/unfit or high-risk acute myeloid leukemia …
N Daver, J Senapati, A Maiti, S Loghavi, TM Kadia, CD DiNardo, ...
Blood 140 (Supplement 1), 141-144, 2022
452022
Immune dysfunction signatures predict outcomes and define checkpoint blockade–unresponsive microenvironments in acute myeloid leukemia
S Rutella, J Vadakekolathu, F Mazziotta, S Reeder, TO Yau, ...
The Journal of Clinical Investigation 132 (21), 2022
432022
TAp63 suppresses mammary tumorigenesis through regulation of the Hippo pathway
X Su, M Napoli, HA Abbas, A Venkatanarayan, NHB Bui, C Coarfa, YJ Gi, ...
Oncogene 36 (17), 2377-2393, 2017
422017
ΔNp63/DGCR8-dependent microRNAs mediate therapeutic efficacy of HDAC inhibitors in cancer
M Napoli, A Venkatanarayan, P Raulji, BA Meyers, W Norton, LS Mangala, ...
Cancer cell 29 (6), 874-888, 2016
412016
Acalabrutinib: a selective Bruton tyrosine kinase inhibitor for the treatment of B-cell malignancies
HA Abbas, WG Wierda
Frontiers in Oncology 11, 668162, 2021
362021
Midostaurin in acute myeloid leukemia: an evidence-based review and patient selection
HA Abbas, M Alfayez, T Kadia, F Ravandi-Kashani, N Daver
Cancer management and research, 8817-8828, 2019
362019
The effect of consanguinity on neonatal outcomes and health
HA Abbas, K Yunis
Human heredity 77 (1-4), 87-92, 2014
332014
Prevalence and correlation of hypothyroidism with pregnancy outcomes among lebanese women
D Ezzeddine, D Ezzeddine, C Hamadi, HA Abbas, A Nassar, M Abiad, ...
Journal of the Endocrine society 1 (5), 415-422, 2017
312017
系统目前无法执行此操作,请稍后再试。
文章 1–20